ArticleCureus2026
Single-Centre Experience of Gallbladder Cancer in the United Kingdom: Do Patients With Incidentally Discovered Malignancy After Gallbladder Surgery Have Better Outcomes?
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Biliary tract cancers refer to a spectrum of invasive tumours, usually adenocarcinomas, arising from the gallbladder or cystic duct (gallbladder carcinoma or GBC) or the biliary tree (cholangiocarcinoma or CCA) and represent a minority of all human cancers. Risk factors of GBC are old age, female gender, and gallstones, which represent the strongest risk factor, in addition to congenital biliary tree malformations and obesity. Methods This was a retrospective review using electronic records of all the patients admitted at a single centre in the UK, between January 2014 and July 2024, who were diagnosed with GBC or dysplasia. The study included 47 patients. Results Forty-seven patients were analysed, with a median age of 72 years. Forty-one of them were female patients, and six were male patients, with a mean BMI of 25.5 and the mode of American Society of Anesthesiologists (ASA) was three. Approximately 80% of the patients had gallstones, and about 70.2% of the cases were diagnosed before having an operation, if any. More than half of the patients (55.3%) had metastatic advanced cancer at the time of diagnosis. Moreover, about 81% of the patients were managed palliatively with either palliative chemotherapy or best supportive care. However, overall mortality was high (76.5%). Conclusion The management of gallbladder cancer requires a multidisciplinary approach, with surgery, chemotherapy, and radiotherapy playing pivotal roles. Our study showed that incidentally discovered gallbladder cancer carries better survival outcomes than symptomatically evident cancer. Radical surgery combined with adjuvant therapies offered the best survival outcomes for early-stages (TIb, T2) and locally advanced GBC (T3). Further research is needed to explore different modalities to screen, diagnose early, and effectively treat advanced cases of GBC, with better survival results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.